Schoenberger SP - Search Results

1

Efficient T cell activation via a Toll-Interleukin 1 Receptor-independent pathway.

Janssen E, Tabeta K, Barnes MJ, Rutschmann S, McBride S, Bahjat KS, Schoenberger SP, Theofilopoulos AN, Beutler B, Hoebe K. Janssen E, et al. Among authors: schoenberger sp. Immunity. 2006 Jun;24(6):787-799. doi: 10.1016/j.immuni.2006.03.024. Immunity. 2006. PMID: 16782034 Free article.

2

CD40L blockade prevents autoimmune diabetes by induction of bitypic NK/DC regulatory cells.

Homann D, Jahreis A, Wolfe T, Hughes A, Coon B, van Stipdonk MJ, Prilliman KR, Schoenberger SP, von Herrath MG. Homann D, et al. Among authors: schoenberger sp. Immunity. 2002 Mar;16(3):403-15. doi: 10.1016/s1074-7613(02)00290-x. Immunity. 2002. PMID: 11911825 Free article.

3

Cross-priming is under control of the relB gene.

Castiglioni P, Janssen EM, Prilliman KR, Gerloni M, Schoenberger S, Zanetti M. Castiglioni P, et al. Scand J Immunol. 2002 Sep;56(3):219-23. doi: 10.1046/j.1365-3083.2002.01144.x. Scand J Immunol. 2002. PMID: 12193222 Free article.

4

CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes.

Janssen EM, Lemmens EE, Wolfe T, Christen U, von Herrath MG, Schoenberger SP. Janssen EM, et al. Among authors: schoenberger sp. Nature. 2003 Feb 20;421(6925):852-6. doi: 10.1038/nature01441. Epub 2003 Feb 9. Nature. 2003. PMID: 12594515

5

A subset of Toll-like receptor ligands induces cross-presentation by bone marrow-derived dendritic cells.

Datta SK, Redecke V, Prilliman KR, Takabayashi K, Corr M, Tallant T, DiDonato J, Dziarski R, Akira S, Schoenberger SP, Raz E. Datta SK, et al. Among authors: schoenberger sp. J Immunol. 2003 Apr 15;170(8):4102-10. doi: 10.4049/jimmunol.170.8.4102. J Immunol. 2003. PMID: 12682240

6

APCs size up antigens.

Bahjat KS, Schoenberger SP. Bahjat KS, et al. Among authors: schoenberger sp. Nat Med. 2004 Jul;10(7):679-81. doi: 10.1038/nm0704-679. Nat Med. 2004. PMID: 15229513 No abstract available.

7

CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death.

Janssen EM, Droin NM, Lemmens EE, Pinkoski MJ, Bensinger SJ, Ehst BD, Griffith TS, Green DR, Schoenberger SP. Janssen EM, et al. Among authors: schoenberger sp. Nature. 2005 Mar 3;434(7029):88-93. doi: 10.1038/nature03337. Nature. 2005. PMID: 15744305

8

Protein kinase C-theta is an early survival factor required for differentiation of effector CD8+ T cells.

Barouch-Bentov R, Lemmens EE, Hu J, Janssen EM, Droin NM, Song J, Schoenberger SP, Altman A. Barouch-Bentov R, et al. Among authors: schoenberger sp. J Immunol. 2005 Oct 15;175(8):5126-34. doi: 10.4049/jimmunol.175.8.5126. J Immunol. 2005. PMID: 16210616

9

IL-2 gets with the program.

Schoenberger SP, Janssen EM. Schoenberger SP, et al. Nat Immunol. 2006 Aug;7(8):798-800. doi: 10.1038/ni0806-798. Nat Immunol. 2006. PMID: 16855604 No abstract available.

10

Cytosolic entry controls CD8+-T-cell potency during bacterial infection.

Bahjat KS, Liu W, Lemmens EE, Schoenberger SP, Portnoy DA, Dubensky TW Jr, Brockstedt DG. Bahjat KS, et al. Among authors: schoenberger sp. Infect Immun. 2006 Nov;74(11):6387-97. doi: 10.1128/IAI.01088-06. Epub 2006 Sep 5. Infect Immun. 2006. PMID: 16954391 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

124 results

Search Page

Filters